Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Coca-Cola reported for 6 months of 2023

7/26/23 KO

Ozon will build in Tula region a logistics center with an area of 60 thousand square meters

7/26/23 OZON

LSR reported for 6 months of 2023 by RAS

7/26/23 LSRG

Rosseti Volga reported for 6 months of 2023 by RAS

7/26/23 MRKV

Sollers may start production of tourist buses

7/26/23 SVAV

Ozon started construction of the largest logistics hub in Kazakhstan

7/26/23 OZON

TMK's Board of Directors recommended dividends for 6 months of 2023

7/26/23 TRMK

Novatek reported for 6 months of 2023 by IFRS

7/26/23 NVTK

Yandex will create for Russia separate data markup service

7/26/23 YNDX

Moscow Exchange changes listing rules

7/26/23 MOEX